Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TERIFLUNOMIDE, with a corresponding US DMF Number 30297.
Remarkably, this DMF maintains an Active status since its submission on March 05, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 13, 2016, and payment made on February 29, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II